NCT00813618 - Study of MEDI 507 in the Treatment of Pediatric Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 1999

Primary Completion Date

June 30, 2004

Study Completion Date

August 31, 2004

Conditions

Graft Versus Host Disease

Interventions

DRUG

MEDI-507

0.012 mg/kg given intravenously on Study Days 0, 3, 6 and 9

DRUG

MEDI-507

0.04 mg/kg given intravenously on Study Days 0, 3, 6 and 9

DRUG

MEDI-507

0.12 mg/kg given intravenously on Study Days 0, 3, 6 and 9

Trial Locations (6)

The Children's Hosp. of Phila., Abramson Ped. Research Center, Philadelphia

Children's Hospital, Birmingham

Univ. of Michigan Medical Center, Ann Arbor

Children's Hospital of Orange County, Orange

Children's Memorial Hospital, Chicago

Hackensack U. Medical Center, Hackensack